HK:2181 Stock Latest News
Company AnnouncementsMabpharm Posts Tenfold Profit Surge on Strong Revenue Growth in First Half 20262M ago2181
Company AnnouncementsMabpharm Sets August Board Meeting to Approve 2026 Interim Results2M ago2181
Company AnnouncementsMabpharm Shareholders Unanimously Approve All AGM Resolutions4M ago2181
Company AnnouncementsMabpharm Wins NMPA Nod for New Denosumab Injection, Eyes Rapid Market Expansion4M ago2181
Company AnnouncementsMabpharm Wins China Approval for Denosumab Osteoporosis Drug, Eyes Global Markets5M ago2181
Company AnnouncementsMabpharm Sets 2026 AGM, Seeks 10% Share Buyback Mandate6M ago2181Company AnnouncementsMabpharm Moves to Update Constitution for Treasury Shares and Digital Governance7M ago2181
Company AnnouncementsMabpharm Swings to Profit on Surging 2025 Revenue and Strong Gross Margins7M ago2181
- Company AnnouncementsMabpharm Sets March 26 Board Meeting to Approve 2025 Annual Results8M ago2181
Company AnnouncementsMabpharm Limited Announces Board and Committee Restructuring1y ago2181
Company AnnouncementsMabpharm Limited Updates Nomination Committee Terms1y ago2181
Company AnnouncementsMabpharm Limited Reports Strong Interim Financial Results for H1 20251y ago2181
Company AnnouncementsMabpharm Limited Schedules Board Meeting for Interim Results1y ago2181Company AnnouncementsMabpharm Limited Announces 2025 Annual General Meeting and Share Repurchase Proposal1y ago2181
- Company AnnouncementsMabpharm Limited Reports Significant Revenue Growth Amidst Financial Challenges1y ago2181
- Company AnnouncementsMabpharm Limited Schedules Board Meeting for Annual Results Review1y ago2181
- Company AnnouncementsMabpharm Gains Approval in Pakistan for Key Drug1y ago2181
Company AnnouncementsMabpharm Gains Indonesian Approval for Key Drug1y ago2181
Company AnnouncementsMabpharm Ends Lease Early for Strategic Growth2y ago2181